Literature DB >> 30658014

Sex differences in schizophrenia, bipolar disorder, and post-traumatic stress disorder: Are gonadal hormones the link?

Andrea Gogos1, Luke J Ney2, Natasha Seymour1,3, Tamsyn E Van Rheenen4,5, Kim L Felmingham6.   

Abstract

In this review, we describe the sex differences in prevalence, onset, symptom profiles, and disease outcome that are evident in schizophrenia, bipolar disorder, and post-traumatic stress disorder. Women with schizophrenia tend to exhibit less disease impairment than men. By contrast, women with post-traumatic stress disorder are more affected than men. The most likely candidates to explain these sex differences are gonadal hormones. This review details the clinical evidence that oestradiol and progesterone are dysregulated in these psychiatric disorders. Notably, existing data on oestradiol, and to a lesser extent, progesterone, suggest that low levels of these hormones may increase the risk of disease development and worsen symptom severity. We argue that future studies require a more inclusive, considered analysis of gonadal steroid hormones and the intricacies of the interactions between them, with methodological rigour applied, to enhance our understanding of the roles of steroid hormones in psychiatric disorders. LINKED ARTICLES: This article is part of a themed section on The Importance of Sex Differences in Pharmacology Research. To view the other articles in this section visit http://onlinelibrary.wiley.com/doi/10.1111/bph.v176.21/issuetoc.
© 2019 The British Pharmacological Society.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30658014      PMCID: PMC6877792          DOI: 10.1111/bph.14584

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  182 in total

1.  Effect of Adjunctive Raloxifene Therapy on Severity of Refractory Schizophrenia in Women: A Randomized Clinical Trial.

Authors:  Jayashri Kulkarni; Emorfia Gavrilidis; Stella M Gwini; Roisin Worsley; Jasmin Grigg; Annabelle Warren; Caroline Gurvich; Heather Gilbert; Michael Berk; Susan R Davis
Journal:  JAMA Psychiatry       Date:  2016-09-01       Impact factor: 21.596

2.  The impact of progesterone on memory consolidation of threatening images in women.

Authors:  Kim L Felmingham; Wing Chee Fong; Richard A Bryant
Journal:  Psychoneuroendocrinology       Date:  2012-04-23       Impact factor: 4.905

Review 3.  Estrogen: a master regulator of bioenergetic systems in the brain and body.

Authors:  Jamaica R Rettberg; Jia Yao; Roberta Diaz Brinton
Journal:  Front Neuroendocrinol       Date:  2013-08-29       Impact factor: 8.606

Review 4.  Role of estrogen treatment in the management of schizophrenia.

Authors:  Jayashri Kulkarni; Emmy Gavrilidis; Roisin Worsley; Emily Hayes
Journal:  CNS Drugs       Date:  2012-07-01       Impact factor: 5.749

5.  The Stanley Foundation Bipolar Treatment Outcome Network. II. Demographics and illness characteristics of the first 261 patients.

Authors:  T Suppes; G S Leverich; P E Keck; W A Nolen; K D Denicoff; L L Altshuler; S L McElroy; A J Rush; R Kupka; M A Frye; M Bickel; R M Post
Journal:  J Affect Disord       Date:  2001-12       Impact factor: 4.839

6.  The combined effect of gender and age on post traumatic stress disorder: do men and women show differences in the lifespan distribution of the disorder?

Authors:  Daniel N Ditlevsen; Ask Elklit
Journal:  Ann Gen Psychiatry       Date:  2010-07-21       Impact factor: 3.455

7.  Association between serum testosterone levels and the severity of negative symptoms in male patients with chronic schizophrenia.

Authors:  Young-Hoon Ko; Sung-Won Jung; Sook-Haeng Joe; Chang-Hyun Lee; Hyun-Gang Jung; In-Kwa Jung; Seung-Hyun Kim; Moon-Su Lee
Journal:  Psychoneuroendocrinology       Date:  2007-03-28       Impact factor: 4.905

8.  Clinical characteristics of women with reproductive cycle-associated bipolar disorder symptoms.

Authors:  Tania A Perich; Gloria Roberts; Andrew Frankland; Carina Sinbandhit; Tanya Meade; Marie-Paul Austin; Philip B Mitchell
Journal:  Aust N Z J Psychiatry       Date:  2016-09-30       Impact factor: 5.744

9.  Trauma at the hands of another: distinguishing PTSD patterns following intimate and nonintimate interpersonal and noninterpersonal trauma in a nationally representative sample.

Authors:  David Forbes; Emma Lockwood; Andrea Phelps; Darryl Wade; Mark Creamer; Richard A Bryant; Alexander McFarlane; Derrick Silove; Susan Rees; Cath Chapman; Tim Slade; Katherine Mills; Maree Teesson; Meaghan O'Donnell
Journal:  J Clin Psychiatry       Date:  2014-02       Impact factor: 4.384

10.  THE CONCISE GUIDE TO PHARMACOLOGY 2017/18: Nuclear hormone receptors.

Authors:  Stephen Ph Alexander; John A Cidlowski; Eamonn Kelly; Neil V Marrion; John A Peters; Elena Faccenda; Simon D Harding; Adam J Pawson; Joanna L Sharman; Christopher Southan; Jamie A Davies
Journal:  Br J Pharmacol       Date:  2017-12       Impact factor: 8.739

View more
  19 in total

1.  Sex: A change in our guidelines to authors to ensure that this is no longer an ignored experimental variable.

Authors:  James R Docherty; S Clare Stanford; Reynold A Panattieri; Steve P H Alexander; Giuseppe Cirino; Christopher H George; Daniel Hoyer; Angelo A Izzo; Yong Ji; Elliot Lilley; Christopher G Sobey; Phil Stanley; Barbara Stefanska; Gary Stephens; Mauro Teixeira; Amrita Ahluwalia
Journal:  Br J Pharmacol       Date:  2019-08-23       Impact factor: 8.739

Review 2.  Neuropsychiatric effects of tamoxifen: Challenges and opportunities.

Authors:  Andrew M Novick; Anthony T Scott; C Neill Epperson; Christopher D Schneck
Journal:  Front Neuroendocrinol       Date:  2020-08-18       Impact factor: 8.606

3.  The importance of sex differences in pharmacology research.

Authors:  Andrea Gogos; Christopher Langmead; Jennifer C Sullivan; Andrew J Lawrence
Journal:  Br J Pharmacol       Date:  2019-11       Impact factor: 8.739

Review 4.  Sex differences in schizophrenia, bipolar disorder, and post-traumatic stress disorder: Are gonadal hormones the link?

Authors:  Andrea Gogos; Luke J Ney; Natasha Seymour; Tamsyn E Van Rheenen; Kim L Felmingham
Journal:  Br J Pharmacol       Date:  2019-03-14       Impact factor: 8.739

Review 5.  Evaluating the evidence for sex differences: a scoping review of human neuroimaging in psychopharmacology research.

Authors:  Korrina A Duffy; C Neill Epperson
Journal:  Neuropsychopharmacology       Date:  2021-11-03       Impact factor: 7.853

6.  Social Construction and Evolutionary Perspectives on Gender Differences in Post-traumatic Distress: The Case of Status Loss Events.

Authors:  Roy Azoulay; Eva Gilboa-Schechtman
Journal:  Front Psychiatry       Date:  2022-05-16       Impact factor: 5.435

7.  Psychoneuroendocrine protocol to comprehensively study sexually dimorphic cognition.

Authors:  Sarah Kheloui; Mathias Rossi; Silke Jacmin-Park; Ophélie Larocque; Morgan Vallée; Philippe Kerr; Olivier Bourdon; Robert-Paul Juster
Journal:  Compr Psychoneuroendocrinol       Date:  2021-03-19

8.  Long-term consequences of peri-adolescent social isolation on social preference, anxiety-like behaviour, and vasopressin neural circuitry of male and female rats.

Authors:  Brianna L Kinley; Robert F Kyne; Tamijah S Lawton-Stone; Deena M Walker; Matthew J Paul
Journal:  Eur J Neurosci       Date:  2021-11-16       Impact factor: 3.698

9.  The effects of early life adversity on growth, maturation, and steroid hormones in male and female rats.

Authors:  Samantha R Eck; Cory S Ardekani; Madeleine Salvatore; Sandra Luz; Eric D Kim; Charleanne M Rogers; Arron Hall; Demetrius E Lee; Sydney T Famularo; Seema Bhatnagar; Debra A Bangasser
Journal:  Eur J Neurosci       Date:  2019-11-24       Impact factor: 3.386

10.  An Assessment of Long-Term Physical and Emotional Quality of Life of Persons Injured on 9/11/2001.

Authors:  Robert M Brackbill; Howard E Alper; Patricia Frazier; Lisa M Gargano; Melanie H Jacobson; Adrienne Solomon
Journal:  Int J Environ Res Public Health       Date:  2019-03-23       Impact factor: 3.390

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.